capsule91

a very positive structure with interesting developments

Long
NSE:AUROPHARMA   AUROBINDO PHARMA
the sandoz acquisition, is going to add 50% of the last fy revenue , with balance sheet leveraged to 0.7 de ratio...

disclaimer... not an investing/trading recommendation
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.